Skip to main content

Page of 22
and
  1. Article

    Open Access

    Nanoparticle delivery of si-Notch1 modulates metabolic reprogramming to affect 5-FU resistance and cell pyroptosis in colorectal cancer

    Nanocarrier delivery of small interfering RNAs (siRNAs) to silence cancer-associated genes is a promising method for cancer treatment. Here, we explored the role and mechanisms of PLAG NPs-delivered si-Notch1 ...

    Dan-dan Li, Jia-cheng **, Xuan-wen Liu, Shu-yang Liu, Fu-jian Ji in Cancer Nanotechnology (2024)

  2. Article

    Open Access

    Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy

    Residual lymph node metastases (RLNM) remained a great concern in the implementation of organ-preserving strategies and led to poor prognosis in locally advanced rectal cancer (LARC). In this study, we aimed t...

    Yujun Cui, Maxiaowei Song, Jian Tie in Journal of Cancer Research and Clinical On… (2024)

  3. Article

    Open Access

    XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

    Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis remains poor. This phase 3 trial ...

    Qiu-Zhong Pan, **g-**g Zhao, Liang Liu in Signal Transduction and Targeted Therapy (2024)

  4. Article

    Open Access

    A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

    Accurate microsatellite instability (MSI) testing is essential for identifying gastric cancer (GC) patients eligible for immunotherapy. We aimed to develop and validate a CT-based radiomics signature to predic...

    Peng-chao Zhan, Shuo Yang, **ng Liu, Yu-yuan Zhang, Rui Wang, Jia-xing Wang in BMC Cancer (2024)

  5. Article

    Open Access

    Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting IFNα-TYK2-STAT-HSPA5 axis

    Rab27A is a small GTPase-mediating exosome secretion, which participates in tumorigenesis of multiple cancer types. Understanding the biological role of Rab27A in non-small cell lung cancer (NSCLC) is of great...

    Yuanyuan Zeng, Jian Zhao, Zhengyan Wu, Yongkang Huang, Anqi Wang in npj Precision Oncology (2024)

  6. Article

    Open Access

    C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription

    Acute myeloid leukemia (AML) with biallelic (CEBPAbi) as well as single mutations located in the bZIP region is associated with a favorable prognosis, but the underlying mechanisms are still unclear. Here, we pro...

    Mengbao Du, Mowang Wang, Meng Liu, Shan Fu in Journal of Experimental & Clinical Cancer … (2024)

  7. Article

    Open Access

    Influential upregulation of KCNE4: Propelling cancer associated fibroblasts-driven colorectal cancer progression

    Colorectal cancer (CRC) is a malignancy of remarkable heterogeneity and heightened morbidity. Cancer associated fibroblasts (CAFs) are abundant in CRC tissues and are essential for CRC growth. Here, we aimed t...

    Zizhen Zhang, Shengde Liu, Zhenghang Wang, Shuo Wang in Cancer Cell International (2024)

  8. Article

    Open Access

    Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer

    Despite epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) have shown remarkable efficacy in patients with EGFR-mutant non-small cell lung cancer (NSCLC), acquired resistance inevitably deve...

    Jian Zhang, Kejia Zhao, Wen**g Zhou, Ran Kang in Signal Transduction and Targeted Therapy (2024)

  9. Article

    Open Access

    Genetic fusion of CCL11 to antigens enhances antigenicity in nucleic acid vaccines and eradicates tumor mass through optimizing T-cell response

    Nucleic acid vaccines have shown promising potency and efficacy for cancer treatment with robust and specific T-cell responses. Improving the immunogenicity of delivered antigens helps to extend therapeutic ef...

    Hailong Qi, Zhongjie Sun, Tianle Gao, Yanling Yao, Yu Wang, Weiwei Li in Molecular Cancer (2024)

  10. Article

    Open Access

    Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1

    Respiratory disease caused by coronavirus infection remains a global health crisis. Although several SARS-CoV-2-specific vaccines and direct-acting antivirals are available, their efficacy on emerging coronavi...

    **ong **e, Qiaoshuai Lan, **yi Zhao in Signal Transduction and Targeted Therapy (2024)

  11. Article

    Open Access

    Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation

    Methylation of the promoters of SHOX2 and RASSF1A (LungMe®) exhibits promise as a potential molecular biomarker for diagnosing lung cancer. This study sought to assess the aberrant methylation of SHOX2 and RAS...

    Jian Liu, Tingting Bian, Bin She, Lei Liu, Hui Sun, Qing Zhang, Jun Zhu in BMC Cancer (2024)

  12. Article

    Open Access

    Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?

    The aim of this study was to compare the therapeutic value and treatment-related complications of radical hysterectomy with those of concurrent chemoradiotherapy (CCRT) for locally resectable (T1a2–T2a1) stage...

    Mei-ling Zhong, Yin-chuan Liu, Jian-tong Yang, Ya-nan Wang, Mei-hong Ao in BMC Cancer (2024)

  13. Article

    Open Access

    From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review

    In tumor therapeutics, the transition from conventional cytotoxic drugs to targeted molecular therapies, such as those targeting receptor tyrosine kinases, has been pivotal. Despite this progress, the clinical...

    Moksada Regmi, Yingjie Wang, Weihai Liu in Journal of Experimental & Clinical Cancer … (2024)

  14. Article

    Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial

    Shu-Qiang Yuan, Run-Cong Nie, Ying **, Cheng-Cai Liang, Yuan-Fang Li in Nature Medicine (2024)

  15. Article

    Open Access

    Prediction of positive pulmonary nodules based on machine learning algorithm combined with central carbon metabolism data

    Lung cancer causes a huge disease burden, and early detection of positive pulmonary nodules (PPNs) as an early sign of lung cancer is extremely important for effective intervention. It is necessary to develop ...

    Jian-jun Liu, Wen-bin Shen, Qi-rong Qin in Journal of Cancer Research and Clinical On… (2024)

  16. Article

    Open Access

    Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC

    Brain metastasis is a common outcome in non-small cell lung cancer, and despite aggressive treatment, its clinical outcome is still frustrating. In recent years, immunotherapy has been develo** rapidly, howe...

    **-Sheng Liu, Yu-**ang Cai, Yong-Ze He, Jian Xu, Su-Fang Tian, Zhi-Qiang Li in BMC Cancer (2024)

  17. Article

    Open Access

    The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions

    Extensive local invasion of glioblastoma (GBM) cells within the central nervous system (CNS) is one factor that severely limits current treatments. The aim of this study was to uncover genes involved in the in...

    Zhiyi Xue, Yan Zhang, Ruiqi Zhao in Journal of Experimental & Clinical Cancer … (2024)

  18. Article

    Open Access

    Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era

    Radiotherapy (RT) is an effective and available local treatment for patients with refractory or relapsed (R/R) aggressive B-cell lymphomas. However, the value of hypofractionated RT in this setting has not bee...

    Cheng Huang, Tian-Lan Tang, Yan-Yan Qiu, Yu-** Lin, Si-Lin Chen in BMC Cancer (2024)

  19. Article

    Open Access

    GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis

    Glutamate dehydrogenase 1 (GLUD1) is an important enzyme in glutamine metabolism. Previously, we found GLUD1 was down-regulated in tumor tissues of hepatocellular carcinoma (HCC) patients by proteomics study. ...

    Qianwei Zhao, Mengdan Yu, **xia Li, Yaoyu Guo, Zexuan Wang, Kefei Hu in Discover Oncology (2024)

  20. Article

    Open Access

    Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial

    This study aimed to evaluate the prognostic role of the baseline neutrophil/lymphocyte ratio (NLR) in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab/pertuzumab.

    Nianhua Ding, Jian Pang, Xuan Liu, **ongbin He, Wei Zhou in Breast Cancer Research (2024)

Page of 22